Chronic Obstructive Pulmonary Disease
📧 Sign up to get email alerts when something new happens for Chronic Obstructive Pulmonary Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-09-13Clinical Trial Update: Effects of Mud Bath Therapy in Chronic Obstructive Pulmonary Disease [NA]
A completed clinical trial evaluated mud bath therapy in patients with chronic obstructive pulmonary disease.
-
CLINICAL_TRIALS trial_result · 2013-09-11Clinical Trial Update: Innate Immune Responses in Chronic Obstructive Pulmonary Disease (COPD) Patients [Phase 3]
A Phase 3 clinical trial update on innate immune responses in patients with Chronic Obstructive Pulmonary Disease; the study status is compl…
-
FDA approval · 2013-09-10FDA Approved: XOPENEX HFA — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved a supplemental application for XOPENEX HFA (levalbuterol tartrate) filed by Lupin Pharmaceuticals, Inc.
-
CLINICAL_TRIALS research · 2013-09-05Clinical Trial Update: Home Telehealth Follow-up After Hospital Discharge for Chronic Obstructive Pulmonary Disease (COPD) Patients [NA]
This entry provides an update on a clinical trial evaluating home telehealth follow-up after hospital discharge for patients with chronic ob…
-
CLINICAL_TRIALS research · 2013-09-04Clinical Trial Update: Daily Magnesium-treatment of Patients With Chronic Obstructive Pulmonary Disease [NA]
A completed clinical trial evaluated daily magnesium treatment in patients with chronic obstructive pulmonary disease. The snippet provides …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2013-09-04Clinical Trial Update: Effects of Laser Therapy on Muscle Function in COPD Patients [NA]
This clinical trial update describes a study evaluating the effects of laser therapy on muscle function in patients with chronic obstructive…
-
CLINICAL_TRIALS trial_result · 2013-09-04Clinical Trial Update: A Long-term Safety Study of Infliximab in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD).
A long-term safety study of infliximab in patients with moderate to severe COPD has completed, with the document summarizing the safety resu…
-
CLINICAL_TRIALS research · 2013-09-04Clinical Trial Update: Serum, Plasma, DNA and Tissue Bank in Chronic Obstructive Pulmonary Disease and Lung Cancer
This clinical trial update describes a biobank at KU Leuven collecting serum, plasma, DNA, and tissue samples from patients with chronic obs…
-
FDA approval · 2013-08-23FDA Approved: DALIRESP — Supplemental Application (AstraZeneca Pharmaceuticals LP)
The FDA approved a supplemental application for DalireSP (roflumilast) from AstraZeneca Pharmaceuticals LP, resulting in an updated label.
-
CLINICAL_TRIALS research · 2013-08-22Clinical Trial Update: AirSonea Wheeze Detection Study [NA]
A status update on the AirSonea wheeze detection clinical trial sponsored by iSonea for COPD and asthma; the current status is unknown.
-
FDA approval · 2013-08-21FDA Approved: DULERA — Supplemental Application (Organon LLC)
FDA approved a supplemental application for DULERA (mometasone furoate and formoterol fumarate dihydrate) by Organon LLC.
-
CLINICAL_TRIALS trial_result · 2013-08-21Clinical Trial Update: Efficacy and Safety of 400 μg Twice Daily of Aclidinium Bromide vs. Placebo When Administered to Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]
A Phase 3 trial evaluated the efficacy and safety of 400 μg aclidinium bromide taken twice daily versus placebo in adults with moderate to s…
-
CLINICAL_TRIALS trial_result · 2013-08-21Clinical Trial Update: Special Drug Use Investigation for ADOAIR (Fluticasone/Salmeterol)
Special Drug Use Investigation for ADOAIR (fluticasone/salmeterol) completed, sponsor GlaxoSmithKline reports.
-
CLINICAL_TRIALS trial_result · 2013-08-20Clinical Trial Update: NPPV Added Inspiratory Muscle Training in Severe COPD [NA]
The document reports an update to a clinical trial evaluating the addition of inspiratory muscle training to non-invasive positive pressure …
-
CLINICAL_TRIALS trial_result · 2013-08-19Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]
Phase 3 clinical trial update assessing the efficacy and safety of Fluticasone Furoate combined with GW642444 inhalation powder in chronic o…
-
CLINICAL_TRIALS trial_result · 2013-08-19Clinical Trial Update: A Study to Evaluate Annual Rate of Exacerbations and Safety of 3 Dosage Strengths of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]
A Phase 3 trial evaluating annual exacerbation rate and safety across three doses of fluticasone furoate/GW642444 inhalation powder in COPD;…
-
CLINICAL_TRIALS trial_result · 2013-08-15Clinical Trial Update: A 6-month Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]
A Phase 3 trial evaluating the efficacy and safety of Fluticasone Furoate combined with GW642444 inhalation powder in chronic obstructive pu…
-
CLINICAL_TRIALS trial_result · 2013-08-15Clinical Trial Update: A Study To Assess Single Dosage Strength Of GW685698/GW642444 Chronic Obstructive Pulmonary Disease (COPD) [Phase 2]
A Phase 2 clinical trial evaluating a single dosage strength of GW685698/GW642444 for chronic obstructive pulmonary disease has completed, w…
-
CLINICAL_TRIALS trial_result · 2013-08-15Clinical Trial Update: Efficacy and Safety Study of Fluticasone Furoate (FF)/GW642444 Inhalation Powder and the Individual Components in Subjects With Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]
Phase 3 trial update on efficacy and safety of Fluticasone Furoate/GW642444 inhalation powder and components in COPD; results posted after c…
-
CLINICAL_TRIALS trial_result · 2013-08-15Clinical Trial Update: Chronic Obstructive Pulmonary Disease: CT Features of Severe Exacerbation
A completed clinical trial from Erasme University Hospital examining CT features during severe COPD exacerbations.
-
CLINICAL_TRIALS research · 2013-08-14Clinical Trial Update: Identification and Dynamics With Cerebral Functional Magnetic Resonance Imaging [NA]
This document reports on a completed clinical trial investigating identification and dynamics of cerebral functional MRI in individuals with…
-
CLINICAL_TRIALS trial_result · 2013-08-14Clinical Trial Update: Non-invasive Ventilation in Severe Chronic Obstructive Pulmonary Disease(COPD) [NA]
This clinical trial update reports the termination of a study evaluating non-invasive ventilation in patients with severe chronic obstructiv…
-
CLINICAL_TRIALS trial_result · 2013-08-12Clinical Trial Update: A Long-term Safety Study of Fluticasone Furoate (FF)/GW642444 in Japanese Subjects With COPD [Phase 3]
This completed Phase 3 long-term safety study evaluated the inhaled combination of fluticasone furoate and vilanterol (FF/GW642444) in Japan…
-
CLINICAL_TRIALS trial_result · 2013-08-09Clinical Trial Update: QVA149 Versus Fluticasone/Salmeterol in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]
A Phase 3 trial comparing QVA149 (indacaterol/glycopyrronium) versus Fluticasone/Salmeterol in Chronic Obstructive Pulmonary Disease complet…
-
CLINICAL_TRIALS trial_result · 2013-08-09Clinical Trial Update: A Study to Compare the Impact of Fulticasone Furoate/Vilanterol vs. Tiotropium on Arterial Stiffness in COPD [Phase 3]
Phase 3 trial comparing Fulticasone Furoate/Vilanterol versus Tiotropium on arterial stiffness in COPD completed with posted results.